A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer

Hong Qi(Fudan University), Zhi‐Ming Shao(Fudan University)

Oncotarget

May 27, 2014

10.18632/oncotarget.2029

Cited by 19

Related Papers

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

|Nature Communications|2018|183

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer

|Journal for ImmunoTherapy of Cancer|2021|55

Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy

|Oncotarget|2015|36

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer

|International Journal of Nanomedicine|2015|21

In vivo <scp>CRISPR</scp> screens identify <scp>RhoV</scp> as a <scp>pro‐metastasis</scp> factor of <scp>triple‐negative</scp> breast cancer

|Cancer Science|2023|12